sir pharma
Sun Pharmaceutical Industries, the country’s largest pharma company, has taken a big step towards strengthening its business. The company has announced to acquire 100 percent of Mumbai-based Innovcare Life Sciences Pvt. Ltd. This deal will be done entirely through cash payment for about Rs 271.2 crore. This acquisition is expected to help Sun Pharma expand its product portfolio and strengthen its hold in the domestic market.
In the information given to the stock exchange on Saturday, Sun Pharma said that it has signed an agreement to buy all the outstanding shares of Innovcare Life Sciences. According to the company, this transaction is expected to be completed on or before July 31, 2026. The acquisition will be an all-cash deal and thereafter, Sun Pharma will have full ownership and control over Innovcare.
Why is Innovcare Life Sciences special?
Innovcare Life Sciences, established on July 21, 2014, is engaged in the marketing, distribution and sale of pharmaceutical drugs, nutraceuticals and cosmeceutical products in India. The company operates only in the Indian market and has witnessed steady growth in its business over the last few years.
Company’s financial position strong
Innovcare’s operating revenue increased to Rs 94.06 crore in FY 2026. Earlier, the company had recorded a revenue of Rs 86.09 crore in FY 2025 and Rs 80.93 crore in FY 2024. The continuously increasing income reflects the strong market position of this company.
What will be the impact on shares?
This acquisition can be considered strategically positive for Sun Pharma. The company may get the benefit of new products and better distribution network. Since the size of the deal is not very big compared to Sun Pharma’s total business, there may not be a big immediate impact on the shares. However, in the long run this step may prove helpful in increasing the growth and income of the company.
Disclaimer: This article is for information only and should not be considered as investment advice in any way. TV9 Bharatvarsha advises its readers and viewers to consult their financial advisors before taking any money-related decisions.
Also read- Flipkart’s continuously growing stature in the e-commerce sector, made progress in the online market.
